Cardiac embolism is a medical condition characterized by the migration of a blood clot, known as an embolus, to the heart's blood vessels. This occurrence disrupts the normal flow of blood and poses a significant threat to cardiovascular health. The embolus can originate within the heart's chambers or arteries or travel from other parts of the body, such as the lungs or pelvic veins. The risk of complications, including strokes or heart attacks, is inherent in cases of cardiac embolism. Preventive measures and management strategies often include the use of anticoagulant medications to minimize the formation of blood clots. Timely identification of underlying causes and risk factors is crucial for effective medical intervention to address and alleviate the impact of cardiac embolism on overall heart health.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States